Dividend Declaration

JPMorgan UK Small Cap Grwth&Inc PLC
10 May 2024
 

JPMorgan UK Small Cap Growth & Income plc (the "Company")

 

Interim Dividend Declaration

 

 

Legal Entity Identifier: 549300PXALXKUMU9JM18

Information disclosed in accordance with DTR 6.1.13

 

The Board of JPMorgan UK Small Cap Growth & Income plc announces that the Company will pay an interim dividend of 6.46 pence per ordinary share for the financial year ending 31st July 2024, as part of the Company's transition to an enhanced dividend policy, following the successful completion of its combination with JPMorgan Mid Cap Investment Trust plc.

The interim dividend of 6.46 pence per ordinary share, which represents 2 per cent. of the unaudited NAV of the Company on 28th February 2024, is expected to be paid on 1st July 2024 to shareholders on the register at the close of business on 24th May 2024 (ex-dividend 23rd May 2024).

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ('DRIP'), which is managed by the Company's registrar. For details on the DRIP, please contact the Company's Registrar, Equiniti Limited. The last election date to participate in the DRIP in relation to the above dividend payment is 10th June 2024.

Under the enhanced dividend policy, the Company will move to pay equal quarterly interim dividends, targeting a 4 per cent. yield on the NAV per annum, calculated on the basis of 4 per cent. of audited NAV as at 31 July each year, being the end of the preceding financial year of the Company. The quarterly interim dividends are expected to be announced in August, November, February and May and expected to be paid in October, January, April and July each year.

 

For further information, please contact:

 

Lucy Dina

For and on behalf of

JPMorgan Funds Limited

0800 20 40 20 or +44 1268 44 44 70 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings